Analyst Ratings for Harmony Biosciences Holdings Inc. (HRMY)
HRMY Rating Summary
HRMY Price Target Summary
- Highest: $70.00 (Oppenheimer)
- Lowest: $28.00 (BofA Securities)
- Average: $45.18
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$45.18 (+19.1%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$45.18 (+19.1%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/15/2026 | Ladenburg Thalmann | Caroline Palomeque | New Coverage | Buy (N/A) |
55.00 (N/A) |
37.51 (37.95) |
1.17% | Details |
| 8/26/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
60.00 (N/A) |
38.95 (37.95) |
-2.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
